Evidence map›Paper›PMID 40584019›Full record

ArticleHealth affairs scholar2025

Early estimates of awareness and uptake of over-the-counter naloxone.

Mireille Jacobson, David Powell

Abstract read
In one paragraph

Article in Health affairs scholar, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mireille JacobsonLeonard Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, United States.ORCID https://orcid.org/0000-0002-4977-8783
David PowellRAND, Arlington, VA 22202, United States.ORCID https://orcid.org/0000-0002-9132-2106

Funding

Optimal Methods for Estimating Policy Effect Heterogeneity in Opioid Policy ResearchP50DA046351 · NIDA · RAND CORPORATION · PI Rosanna Smart · 2018 to 2026
$20.8M
A National Survey on Naloxone Use and AccessR21DA060711 · NIDA · RAND CORPORATION · PI POWELL, DAVID · 2024 to 2024
$425k
NIDA NIH HHS P50 DA046351NIDA NIH HHS R21 DA060711
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

naloxone accessopioid crisisover-the-counter medications

Identifiers

PMID40584019
PMCPMC12202286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.